Is It Time to Retire Cholesterol Tests?

This Science news article from 2017 asks a pointed question: should standard cholesterol panels be replaced by apolipoprotein B measurement? It synthesizes emerging genetic and clinical evidence suggesting ApoB captures cardiovascular risk more accurately than LDL-C, particularly when the two measures are discordant — as occurs in patients with small, dense LDL particles, metabolic syndrome, or normal-to-low LDL paired with elevated particle count.

The article’s core argument draws on Mendelian randomization studies showing that ApoB is more directly tied to cardiovascular event risk than LDL-C. ApoB counts atherogenic particles directly — each LDL, VLDL, IDL, and Lp(a) particle carries exactly one ApoB molecule — while LDL-C measures cholesterol mass within LDL, which can vary substantially between individuals with equivalent particle numbers. A patient with small dense LDL particles may have a normal LDL-C and still carry a large atherogenic particle burden; ApoB would capture this while LDL-C would not.

The article identifies the obstacle accurately: clinical inertia. Laboratory infrastructure, reimbursement policies, and 50 years of guideline-embedded LDL-C measurement make change slow. Researchers interviewed express confidence in ApoB’s superiority but acknowledge that widespread adoption requires both guideline endorsement and billing infrastructure.

This is a secondary news piece, not original research. Evidence strength reflects the quality of journalism — transparent about conflicts, fair to multiple perspectives — but not the strength of the primary evidence. The primary evidence for ApoB superiority has continued to accumulate since 2017 and is substantially stronger today.

We rate the evidence limited for this source alone. A 2017 Science news article synthesizing expert opinion and emerging genetic evidence for ApoB over LDL-C — useful context for understanding why the field is moving away from LDL-C, but not a substitute for the primary evidence it summarizes.